Data from MHRA (Medicines and Healthcare products Regulatory Agency, UK) - Curated by Toby Galbraith - Last updated 14 March 2017


Actikerall is indicated for the topical treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (grade I/II) in immunocompetent adult patients.

Grade I/II intensity is based on the 4-point scale of Olsen et al. (1991).

Full Prescribing information

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Breakthrough Cancer Pain Learning Zone

Invitation to watch the online broadcast of the BeCOn OWN event 'Shifting paradigms in BTcP management' on June 16 2017.

Visit Breakthrough Cancer Pain Learning Zone

Chronic Spontaneous Urticaria (CSU)

Use our patient case studies to discover how experts diagnose and treat chronic spontaneous urticaria

+ 3 more

Visit Chronic Spontaneous Urticaria (CSU)

Related Content

More information

Category Value
Authorisation number PL 33016/0015
Orphan designation No
Date First Approved 03-06-2011
Type POM
Marketing authorisation holder Almirall Hermal GmbH